Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

China Pharma Holdings (CPHI) Invested Capital (2016 - 2025)

China Pharma Holdings (CPHI) has disclosed Invested Capital for 16 consecutive years, with $9.7 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Invested Capital rose 28.5% year-over-year to $9.7 million, compared with a TTM value of $9.7 million through Sep 2025, up 28.5%, and an annual FY2024 reading of $8.9 million, up 3.54% over the prior year.
  • Invested Capital was $9.7 million for Q3 2025 at China Pharma Holdings, up from $7.9 million in the prior quarter.
  • Across five years, Invested Capital topped out at $11.2 million in Q3 2021 and bottomed at $4.7 million in Q4 2022.
  • Average Invested Capital over 5 years is $8.3 million, with a median of $8.4 million recorded in 2024.
  • The sharpest move saw Invested Capital crashed 54.29% in 2022, then soared 81.57% in 2023.
  • Year by year, Invested Capital stood at $10.3 million in 2021, then crashed by 54.29% to $4.7 million in 2022, then skyrocketed by 81.57% to $8.6 million in 2023, then rose by 3.54% to $8.9 million in 2024, then increased by 9.38% to $9.7 million in 2025.
  • Business Quant data shows Invested Capital for CPHI at $9.7 million in Q3 2025, $7.9 million in Q2 2025, and $8.1 million in Q1 2025.